AC Immune (ACIU) Common Equity (2014 - 2026)
AC Immune's Common Equity was $44.5 million in the quarter ended Jun 30, 2026, down 50.7% from $90.28 million a year earlier but up 10.5% from the prior quarter.
Powered by 
Analysis
AC Immune (ACIU) Common Equity (2014 - 2026) Analysis & Trends
As of Dec 31, 2025, Common Equity at AC Immune came in at $54.14 million, down 57.6% from the prior year.
- Common Equity shows a five-year compound annual growth rate of -25.1% (years ended Dec 2020 to Dec 2025).
- In earlier years, Common Equity was $127.62 million in the year ended Dec 31, 2024 (-28.7%), $178.87 million in the year ended Dec 31, 2023 (+1.0%), $177.15 million in the year ended Dec 31, 2022 (-30.2%) and $253.87 million in the year ended Dec 31, 2021 (+10.5%).
- Quarterly Common Equity has moved between $40.27 million (the quarter ended Mar 31, 2026) and $251.58 million (the quarter ended Dec 31, 2021) over five years.
- Compared with a year earlier, Common Equity has declined for seven straight quarters, with an average decline of 38.8% over the last eight quarters.
- The best year-over-year quarter for Common Equity over five years was the quarter ended Sep 30, 2024 (growth of 5.6%); the worst was the quarter ended Mar 31, 2026 (a decline of 61.8%).
- Per Business Quant data, ACIU's Common Equity in the three quarters before the quarter ended Jun 30, 2026 was $40.27 million (quarter ended Mar 31, 2026), $56.16 million (quarter ended Dec 31, 2025) and $78.06 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | AC Immune | 265.55 Mn | 265.55 Mn | - | 44.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.50 Mn |
| Mar 31, 2026 | 40.27 Mn |
| Dec 31, 2025 | 56.16 Mn |
| Sep 30, 2025 | 78.06 Mn |
| Jun 30, 2025 | 90.28 Mn |
| Mar 31, 2025 | 105.44 Mn |
| Dec 31, 2024 | 128.16 Mn |
| Sep 30, 2024 | 150.24 Mn |
| Jun 30, 2024 | 136.48 Mn |
| Mar 31, 2024 | 165.76 Mn |
| Dec 31, 2023 | 181.10 Mn |
| Sep 30, 2023 | 142.27 Mn |
| Jun 30, 2023 | 154.96 Mn |
| Mar 31, 2023 | 165.35 Mn |
| Dec 31, 2022 | 175.42 Mn |
| Sep 30, 2022 | 196.79 Mn |
| Jun 30, 2022 | 210.58 Mn |
| Mar 31, 2022 | 231.86 Mn |
| Dec 31, 2021 | 251.58 Mn |
| Sep 30, 2021 | 195.19 Mn |
API Access
AC Immune Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ACIU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ACIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ACIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();